Test Updates
Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.
| Test Update | Date |
|---|---|
SARS-CoV-2 (COVID-19) Nasal Collections for Non-Exposure Patients On August 3, 2020 Clinical Labs of Hawaii will begin offering nasal (anterior nares) collection of SARS-CoV-2 specimens at select locations. | 2020_08_04 |
SARS-CoV-2 (COVID-19) Testing - Patient Data Collection Requirement On June 4, 2020, the U.S. Department of Health and Human Services (HHS) published new requirements for patient data collection and reporting for COVID-19 test results. Please review this bulletin for more details. | 2020_07_25 |
SARS-CoV-2 (COVID-19) Molecular Testing - Specimen Types Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) molecular testing specimen types. | 2020_07_04 |
SARS-CoV-2 (COVID-19) Molecular Testing for Travelers - Frequently Asked Questions Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) molecular testing for travelers. | 2020_06_29 |
SARS-CoV-2 (COVID-19) Molecular Testing Frequently Asked Questions Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) molecular testing. | 2020_06_29 |
SARS-CoV-2 (COVID-19) Molecular Testing On May 19, 2020, Clinical Laboratories of Hawaii (CLH) began testing for SARS-CoV-2, the virus that causes COVID-19, using a new high-throughput system, called the Aptima® SARS-CoV-2 Assay conducted on the Hologic Panther instrument. | 2020_06_29 |
Please review guidelines from the federal government’s COVID-19 Uninsured Program. | 2020_05_12 |
SARS-CoV-2 (COVID-19) Serology Testing Frequently Asked Questions Please review the Clinical Labs of Hawaii frequently asked questions for answers regarding SARS-CoV-2 (COVID-19) serology testing. | 2020_05_06 |
SARS-CoV-2 (COVID-19) Serology Testing Available Effective April 30, 2020, Clinical Labs of Hawaii began offering serology testing for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). | 2020_04_30 |
United Healthcare Insurance March 1, 2020 Billing Update Beginning March 1, 2020, United Healthcare Insurance will require prior authorization/notification for genetic and molecular testing performed in an outpatient setting. | 2020_03_01 |
CLH offers the FilmArray Respiratory Panel from BioFire Diagnostics for the detection of 17 respiratory viruses and 3 bacteria from a single specimen. This panel does NOT test for the SARS-CoV-2 virus. | 2020_02_14 |
Biotin Interference Test Update Biotin administration (especially in high doses) may impact common, immunoassay-based, laboratory tests. | 2020_01_15 |
Human Papillomavirus (HPV) New Methodology and Algorithm CLH/PPPL will be performing Human Papillomavirus (HPV) testing locally on Oahu using the Aptima nucleic acid amplification assay. | 2019_11_11 |